Cardiosense appoints John Martin as chief medical officer

The appointment comes weeks after the company received 510(k) clearance for its wearable heart monitor.

Hospitals prepare for $149B cut to Medicaid state-directed payments

New limits to the program could force hospitals to slash capital spending while bracing for millions of newly uninsured patients.

SetPoint Medical secures $140M to fund neuromodulation for arthritis

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.

Heartflow’s IPO raises $364M

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid investor enthusiasm.

FDA approves Thermo Fisher’s diagnostic test for new NSCLC treatment

As AI spreads through health care, is the technology degrading providers’ skills?

Q&A: The Conference Board responds to Trump administration’s AI Action Plan